Free Republic

I don't see any other logical reason for him speaking the way he did.

A study published Tuesday in the journal Clinical Infectious Diseases showed the controversial daily pill preexposure prophylaxis (PrEP) prevented HIV infection in all 657 patients who took it for two and a half years. The Food and Drug Administration (FDA) in 2012 approved a fixed-dose treatment of emtricitabine and tenofovir for people who do not have HIV but may be at risk of contracting it. Those antiviral drugs comprise PrEP, sold under the brand name Truvada, which can keep HIV infection at bay when an individual is exposed from injection drug use or unprotected sex. “Our study is the first...

Dr. Gorbee Logan has given the drug, lamivudine, to 15 Ebola patients, and all but two survived. That's about a 13% mortality rate. Logan said he got the idea to try lamivudine when he read in scientific journals that HIV and Ebola replicate inside the body in much the same way. "Ebola is a brainchild of HIV," he said. "It's a destructive strain of HIV." At first he tried a drug called acyclovir, which is often given to HIV patients to treat infections that occur with their weakened immune systems. But it didn't seem to be effective. Then he tried...

Close window Published online: 31 August 2007; | doi:10.1038/news070827-7 HIV drug tackles cancer cellsTumour growth blocked by anti-HIV agent.Mary MuersA type of drug commonly used to treat HIV can slow the growth of cancer cells, researchers have found. The discovery raises hopes that drugs developed to fight one killer disease could help tackle another. The HIV drug nelfinavir is now going through its first trial in patients with a range of cancers, in light of the new evidence. Cancer scientists think that by 'repositioning' drugs already approved as HIV therapies, they could help to save lives by reducing the...